Literature DB >> 12830143

The problem of plain vanilla peptides.

Mark M Davis.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12830143     DOI: 10.1038/ni0703-649

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  5 in total

1.  Developing efficient vanillin biosynthesis system by regulating feruloyl-CoA synthetase and enoyl-CoA hydratase enzymes.

Authors:  Qi Hang Chen; Dao Tao Xie; Shan Qiang; Ching Yuan Hu; Yong Hong Meng
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-11       Impact factor: 4.813

2.  Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.

Authors:  Sophie A Valkenburg; Tracy M Josephs; E Bridie Clemens; Emma J Grant; Thi H O Nguyen; George C Wang; David A Price; Adrian Miller; Steven Y C Tong; Paul G Thomas; Peter C Doherty; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-31       Impact factor: 11.205

3.  Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination.

Authors:  Vanessa Venturi; Katherine Kedzierska; David A Price; Peter C Doherty; Daniel C Douek; Stephen J Turner; Miles P Davenport
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-27       Impact factor: 11.205

4.  Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitope.

Authors:  InYoung Song; Anna Gil; Rabinarayan Mishra; Dario Ghersi; Liisa K Selin; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2017-02-27       Impact factor: 15.369

5.  Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.

Authors:  Peng Bai; Yongzheng Li; Qiuping Zhou; Jiaqi Xia; Peng-Cheng Wei; Hexiang Deng; Min Wu; Sanny K Chan; John W Kappler; Yu Zhou; Eric Tran; Philippa Marrack; Lei Yin
Journal:  Oncoimmunology       Date:  2021-01-15       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.